EMEA-001861-PIP01-15
Key facts
| Active substance |
|
| Therapeutic area |
Pain
|
| Decision number |
P/0142/2016
|
| PIP number |
EMEA-001861-PIP01-15
|
| Pharmaceutical form(s) |
Gel
|
| Condition(s) / indication(s) |
Treatment of musculoskeletal and connective tissue pain and discomfort
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|